This "promising first step" could help to treat bladder, oral, head and neck tumors more effectively, said biomedical ...

FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive ...

A recent study reveals low rates of upper tract urothelial carcinoma in non-muscle-invasive bladder cancer, prompting a ...

Bladder cancer, often misunderstood, affects both men and women, not just the elderly. While smoking is a significant risk factor, genetics and chemic ...

Bladder Cancer is a disease where cancer cells form in the tissues of the bladder. More common in males than females over 55 years of age, the cancer is known to cause blood in urine, which is ...

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from ...

The bladder cancer condition center is a comprehensive resource for cancer news & oncologist insights on bladder cancer. Read more about cancer at CURE.

The New Brunswick, N.J., pharmaceutical giant on Thursday said the application covers TAR-200 for the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle invasive ...

Bladder cancer articles from across Nature Portfolio Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell carcinomas (cancer that begins in ...

BCG therapy—the gold standard treatment for non-muscle invasive bladder cancer (NMIBC), where the cancer has not penetrated the muscle layer—is one of the earliest forms of cancer ...

We conducted a retrospective cohort study of patients with bladder cancer registered in the Registro Hospitalar de Câncer da Fundação Oncocentro de São Paulo, a large state-wide database. Eligibility ...